These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 19443701)

  • 1. Coordinate expression of colony-stimulating factor-1 and colony-stimulating factor-1-related proteins is associated with poor prognosis in gynecological and nongynecological leiomyosarcoma.
    Espinosa I; Beck AH; Lee CH; Zhu S; Montgomery KD; Marinelli RJ; Ganjoo KN; Nielsen TO; Gilks CB; West RB; van de Rijn M
    Am J Pathol; 2009 Jun; 174(6):2347-56. PubMed ID: 19443701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of tumor-associated macrophages in leiomyosarcoma: a single institution study.
    Ganjoo KN; Witten D; Patel M; Espinosa I; La T; Tibshirani R; van de Rijn M; Jacobs C; West RB
    Am J Clin Oncol; 2011 Feb; 34(1):82-6. PubMed ID: 23781555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF1 expression in nongynecological leiomyosarcoma is associated with increased tumor angiogenesis.
    Espinosa I; Edris B; Lee CH; Cheng HW; Gilks CB; Wang Y; Montgomery KD; Varma S; Li R; Marinelli RJ; West RB; Nielsen T; Beck AH; van de Rijn M
    Am J Pathol; 2011 Oct; 179(4):2100-7. PubMed ID: 21854753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNAscope CSF1 chromogenic in situ hybridization: a potentially useful tool in the differential diagnosis of tenosynovial giant cell tumors.
    Thangaiah JJ; Koepplin JW; Folpe AL
    Hum Pathol; 2021 Sep; 115():1-9. PubMed ID: 34058245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translocation and expression of CSF1 in pigmented villonodular synovitis, tenosynovial giant cell tumor, rheumatoid arthritis and other reactive synovitides.
    Cupp JS; Miller MA; Montgomery KD; Nielsen TO; O'Connell JX; Huntsman D; van de Rijn M; Gilks CB; West RB
    Am J Surg Pathol; 2007 Jun; 31(6):970-6. PubMed ID: 17527089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of M-CSF and CSF-1R is correlated with histological grade in soft tissue tumors.
    Richardsen E; Sørbye SW; Crowe JP; Yang JL; Busund LT
    Anticancer Res; 2009 Oct; 29(10):3861-6. PubMed ID: 19846920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of fibroblast growth factor 2 in patients with uterine smooth muscle tumors: an immunohistochemical study.
    Bodner-Adler B; Mayerhofer K; Czerwenka K; Kimberger O; Koelbl H; Bodner K
    Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():62-67. PubMed ID: 27825029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour.
    Edris B; Espinosa I; Mühlenberg T; Mikels A; Lee CH; Steigen SE; Zhu S; Montgomery KD; Lazar AJ; Lev D; Fletcher JA; Beck AH; West RB; Nusse R; van de Rijn M
    J Pathol; 2012 Jun; 227(2):223-33. PubMed ID: 22294416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The selected biomarker analysis in 5 types of uterine smooth muscle tumors.
    Zhang Q; Kanis MJ; Ubago J; Liu D; Scholtens DM; Strohl AE; Lurain JR; Shahabi S; Kong B; Wei JJ
    Hum Pathol; 2018 Jun; 76():17-27. PubMed ID: 29258902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuron navigator-2 and cyclin D2 are new candidate prognostic markers in uterine sarcoma.
    Davidson B; Hellesylt E; Holth A; Danielsen HE; Skeie-Jensen T; Katz B
    Virchows Arch; 2017 Sep; 471(3):355-362. PubMed ID: 28643014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcl-2 expression and other clinicopathologic parameters in uterine leiomyosarcoma.
    Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
    Wien Klin Wochenschr; 2004 Feb; 116(4):135-9. PubMed ID: 15038405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor II messenger RNA-binding protein-3 is an independent prognostic factor in uterine leiomyosarcoma.
    Yasutake N; Ohishi Y; Taguchi K; Hiraki Y; Oya M; Oshiro Y; Mine M; Iwasaki T; Yamamoto H; Kohashi K; Sonoda K; Kato K; Oda Y
    Histopathology; 2018 Apr; 72(5):739-748. PubMed ID: 29077232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The macrophage colony-stimulating factor 1 response signature in breast carcinoma.
    Beck AH; Espinosa I; Edris B; Li R; Montgomery K; Zhu S; Varma S; Marinelli RJ; van de Rijn M; West RB
    Clin Cancer Res; 2009 Feb; 15(3):778-87. PubMed ID: 19188147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells.
    West RB; Rubin BP; Miller MA; Subramanian S; Kaygusuz G; Montgomery K; Zhu S; Marinelli RJ; De Luca A; Downs-Kelly E; Goldblum JR; Corless CL; Brown PO; Gilks CB; Nielsen TO; Huntsman D; van de Rijn M
    Proc Natl Acad Sci U S A; 2006 Jan; 103(3):690-5. PubMed ID: 16407111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine Leiomyosarcoma Tumorigenesis in Lmp2-deficient Mice: Involvement of Impaired Anti-oncogenic Factor IRF1.
    Hayashi T; Horiuchi A; Sano K; Yaegashi N; Konishi I
    Anticancer Res; 2015 Sep; 35(9):4665-79. PubMed ID: 26254356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progesterone Receptor Expression Is an Independent Prognosticator in FIGO Stage I Uterine Leiomyosarcoma.
    Davidson B; Kjæreng ML; Førsund M; Danielsen HE; Kristensen GB; Abeler VM
    Am J Clin Pathol; 2016 Apr; 145(4):449-58. PubMed ID: 27149024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic role of E-cadherin and Vimentin expression in various subtypes of soft tissue leiomyosarcomas.
    Tian W; Wang G; Yang J; Pan Y; Ma Y
    Med Oncol; 2013 Mar; 30(1):401. PubMed ID: 23292832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TOP2A copy number and TOP2A expression in uterine benign smooth muscle tumours and leiomyosarcoma.
    Baiocchi G; Poliseli FL; De Brot L; Mantoan H; Schiavon BN; Faloppa CC; Vassallo J; Soares FA; Cunha IW
    J Clin Pathol; 2016 Oct; 69(10):884-9. PubMed ID: 26994023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential diagnostic biomarkers: differential expression of LMP2/β1i and cyclin B1 in human uterine leiomyosarcoma.
    Hayashi T; Horiuchi A; Sano K; Hiraoka N; Ichimura T; Sudo T; Ishiko O; Yaegashi N; Aburatani H; Konishi I
    Tumori; 2014; 100(4):99e-106e. PubMed ID: 25296613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of von Willebrand factor, CD34, CD31, and vascular endothelial growth factor expression in women with uterine leiomyosarcomas.
    Poncelet C; Fauvet R; Feldmann G; Walker F; Madelenat P; Darai E
    J Surg Oncol; 2004 May; 86(2):84-90. PubMed ID: 15112250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.